New FDA-Approved Treatment for RKD

The FDA has approved Ultomiris for adults with IgA Nephropathy (IgAN). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Jorden Albright

Community Leader

Jorden Albright joined the Nephcure team in January 2023 as the Volunteer Community Leader for the City of Atlanta. He brings years of experience in networking and relationship-building expertise, with a background in the film and entertainment industry, as well as his profession as an Associate at Rise Property Group - a Commercial Real Estate Brokerage in Atlanta. Jorden attributes his involvement in advocation stemming from his younger brother being diagnosed with a rare kidney disease called APOL-1 FSGS, which he too was later diagnosed with. After seeing his brother persevere and be able to spread positivity and awareness throughout uncertain times, he decided that he wanted to do the same. 

Jorden resides in Atlanta, Georgia with roots in Northern California. He enjoys spending his free time staying active, doing DIY projects, water/snow sports, traveling and gardening. 

NephCure Email: jordenalbright@nephcurevolunteer.org

Atlanta, GA

Related News

NEWS

The FDA Grants Accelerated Approval of ULTOMIRIS (ravulizumab-cwvz) for Adults with IgA Nephropathy 

NEWS

NephCure Applauds U.S. Department of Health and Human Services on the Release of the Rare Kidney Disease Inclusive Kidney Care National Plan

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.